Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

The Holistic Sanctuary Responds to the FDA’s Recommendation for Tighter Controls on Painkillers
  • USA - English


News provided by

The Holistic Sanctuary

Oct 25, 2013, 12:35 ET

Share this article

Share toX

Share this article

Share toX

Vimeo
Vimeo

Los Angeles, CA (PRWEB) October 25, 2013 -- The Holistic Sanctuary announces its response to the Food and Drug Administration’s (FDA) just-released report about the need for tighter controls on how doctors prescribe the most commonly used narcotic painkillers.(1) The recommendation, as covered by the New York Times, follows a decade-long debate over whether the widely abused drugs, which contain the narcotic hydrocodone, should be controlled as strongly as painkillers like oxycontin.(2)

The Holistic Sanctuary is, however, the sole destination where healing – of the mind, body and spirit – is real, consistent and permanent. We end addiction, period, while never using prescription medicines, outdated theories or other antiquated concepts.

Post this

At the same time, The Holistic Sanctuary emphasizes its sustained campaign to permanently end addiction to opiates in general, as well as other illicit substances, alcohol and prescription medications.

The FDA’s statement comes in the midst of a national epidemic involving addiction, in which prescription drugs account for approximately three-quarters of all drug overdose deaths in the United States, quadrupling since 1999, according to the National Survey on Drug Use & Health.(3) In fact, Americans consume 80% of opiate painkillers produced in the world, based on findings compiled by the American Society of International Pain Physicians.(4) Even worse, every hour, a baby is born in the United States with symptoms of opiate withdrawal, as revealed by the Journal of the American Medical Association (JAMA).(5)

More specifically, antidepressants such as zoloft and celexa are – according to the journal ACS Chemical Neuroscience – the most prescribed class of drugs, with 264 million prescriptions filled, with another 131 million prescriptions written for the generic version of vicodin.(6) Overall, a record 4.02 billion drug prescriptions were written in the U.S. in 2011 (the most recent year for these statistics), up from 3.99 billion the year before.(7)

In addition, 31.9 million prescriptions were written for generic percocet, while 29.3 million were written for generic neurontin, which is frequently prescribed for long-term pain.(8) Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, states: “These are very difficult trade-offs that our society has to make. The reason we approve these drugs is for people in pain. But we can’t ignore the epidemic on the other side.”(9)

To further illustrate the severity of this epidemic, about 131 million prescriptions for hydrocodone-containing medications were written for about 47 million patients, according to government estimates. That amounts to about five billion pills.(10) Potential side effects from these drugs include: Swelling of the face, mouth, and throat, difficulty breathing, itching, rash or possible liver failure,(11) as well as a severe skin reaction known as Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), and acute generalized exanthematous pustulosis (AGEP), which can be fatal.(12)

These alarming statistics, self-described (by the FDA) as an epidemic, stand in contrast to The Holistic Sanctuary’s safe, exclusive and all-natural efforts to successfully heal the brain and permanently end addiction to these drugs. Conventional rehab centers, on the other hand, often lack any controlled studies of their outcomes, according to Bankole A. Johnson, Chairman of the Department of Psychiatry and Neurobehavioral Sciences at the University of Virginia.(13) Compounding the problem is the fact that many of these facilities do not even follow up with former patients.(14)

For Johnny Tabaie, “Johnny The Healer,” (see also http://www.johnnythehealer.com/) the Founder of The Holistic Sanctuary, eliminating addiction to opiates – along with the combination of prescription drugs, which constitutes a so-called “chemical cocktail” – is the essence of his safe, well-researched (and confirmed, through double-blind studies) and effective solution known as the Pouyan Method. This treatment pinpoints and reverses the root causes of addiction, restoring and rejuvenating brain cells damaged by drug abuse.

Most importantly, Johnny does not classify addiction as an incurable disease or a lifelong emotional albatross. His inspiring and diverse video testimonials from guests are a testament to this belief, proving there is an escape from the relapse-to-rehab revolving door of pain, despair and financial ruin. People can view these powerful stories at: theholisticsanctuary.com/Ibogaine-Videos/

“The FDA’s belated announcement does nothing to properly treat – never mind cure – addiction to opiates and other painkillers. We can already extrapolate from existing data, and predict that this epidemic will continue to increase, causing real harm (such as irreversible physical damage for a significant amount of people, or even death among thousands of people) with no attempt by the FDA or conventional drug rehab centers to stop this problem. The Holistic Sanctuary is, however, the sole destination where healing – of the mind, body and spirit – is real, consistent and permanent. We end addiction, period, while never using prescription medicines, outdated theories, attack therapy or other antiquated concepts. We heal your brain so you can heal your life,” says Mr. Tabaie.

Prospective guests can examine the indisputable evidence of The Holistic Sanctuary’s actions concerning the repair, restoration and rejuvenation of the areas damaged from addiction by clicking Pouyan Method Brain Scans (theholisticsanctuary.com/Brain-Scan/).

About The Holistic Sanctuary

The Holistic Sanctuary is the home of the exclusive, all-natural and proprietary Pouyan Method, which enables patients to permanently end a variety of addictions. Unlike conventional drug and alcohol rehabilitation centers, which have rates or failure or relapse among patients, The Holistic Sanctuary offers a customized protocol with the amenities of a 5-star resort. We seek to stop addiction without prescription medication or the use of 12-step programs. Nor do we classify patients as victims of an incurable disease. Our therapies focus on healing the brain, so a patient can heal their life. For more information about our innovative techniques, founding principles and testimonials from former patients, please visit http://www.theholisticsanctuary.com.

1. nytimes.com/2013/10/25/business/fda-seeks-tighter-control-on-prescriptions-for-class-of-painkillers.html?_r=0
2. nytimes.com/2013/10/25/business/fda-seeks-tighter-control-on-prescriptions-for-class-of-painkillers.html?_r=0
3. oas.samhsa.gov/nhsda.htm
4. asipp.org/documents/ASIPPFactSheet101111.pdf
5. jama.jamanetwork.com/content/early/2012/04/25/jama.2012.3951.full
6. acs.org/content/acs/en/pressroom/presspacs/2012/acs-presspac-september-12-2012.html
7. acs.org/content/acs/en/pressroom/presspacs/2012/acs-presspac-september-12-2012.html
8. acs.org/content/acs/en/pressroom/presspacs/2012/acs-presspac-september-12-2012.html
9. fda.gov/Drugs/DrugSafety/ucm372089.htm
10. fda.gov/Drugs/DrugSafety/ucm372089.htm
11. fda.gov/drugs/drugsafety/ucm239821.htm
12. fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm363519.htm
13. uvamagazine.org/features/article/targeting_addiction/#.Umn4Jjm-Iao
14. washingtonpost.com/wp-dyn/content/article/2010/08/06/AR2010080602660_2.html

Johnny Tabaie, The Holistic Sanctuary, http://www.theholisticsanctuary.com, +1 3236069904, [email protected]

Modal title

Addiction Cure Center Paradise
Addiction Cure Center Paradise
5 Star Healing Addiction Center
5 Star Healing Addiction Center
Natural High, Weekend Excursions
Natural High, Weekend Excursions
Weekend Atv and Excursions
Weekend Atv and Excursions
The Holistic Sanctuary
The Holistic Sanctuary
Addiction Cure Center Paradise 5 Star Healing Addiction Center Natural High, Weekend Excursions Weekend Atv and Excursions The Holistic Sanctuary

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.